Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ANIXA BIOSCIENCES, INC. (ANIX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ANIXA BIOSCIENCES, INC. (ANIX), most recent 12 months reported: net loss $10.38M. Latest balance sheet on file: liquid cash $13.86M. From SEC filings. Others in Pharmaceutical Preparations: ALX ONCOLOGY HOLDINGS INC · ALZAMEND NEURO, INC. · Amylyx Pharmaceuticals, Inc. · ANEBULO PHARMACEUTICALS, INC. · ANNEXON, INC. · Alto Neuroscience, Inc. · AN2 Therapeutics, Inc. · Annovis Bio, Inc.

Stock screener

Watchlist